Hong Kong Market Close: Hang Seng Index Up 0.6%, Commercial Aerospace Surges, Computing Power Stocks Pull Back
Miles Bennett
The Hang Seng Index closed up 0.6% at 24,175 on July 10 as afternoon flows rotated sharply out of chip-hardware names and into commercial space and innovative pharma — a rocket-recovery breakthrough and a drug-catalog overhaul each lit a fresh thematic line while lockup-expiry pressure dragged AI-compute stocks lower.
How did the broader market finish?
The HSI closed at 24,175.12, up 0.6%. The Hang Seng Tech Index flipped negative in the afternoon, ending down 0.21% at 4,721.66. Turnover hit HK$339.6 billion.
For the week, the HSI gained 3.53%, the HSCEI 4.41%, and the Tech Index 4.95%.
This means → all three benchmarks posted solid weekly gains, but Friday's late tech sell-off signals money actively trimmed tech exposure ahead of the weekend.
A rocket landed — why did space stocks take off?
China's Long March 10B lifted off on July 10 and its first-stage booster landed vertically on a sea platform — making China the second country to master large-payload reusable-rocket technology.
The news ignited the sector in the afternoon: Junda Holdings surged 24.2%, Goldwind Technology rose 8.4%, APT Satellite gained 4.27%.
In plain terms = a reusable rocket slashes launch costs; cheaper launches make mass satellite-constellation deployment viable. Everbright Securities sees the industry unfolding along one chain: cut costs → deploy satellites → build networks → unlock downstream apps.
What is driving the innovative-pharma rally?
Three government agencies on July 9 published the 2026 National Essential Medicines List, adding 16 innovative drugs for the first time in bulk — including 4 domestically developed Class-I new drugs.
In plain terms = landing on the essential list means hospitals must prioritize procurement, giving sales a policy floor.
Kelun-Biotech rose 8.74%, SSY Group gained 6.29%, InnoCare climbed 4.25%. Extra fuel: China's first-half 2026 out-licensing deals totaled US$99.7 billion, already 73% of 2025's full-year figure.
Why did chip-hardware stocks sell off instead?
GigaDevice (03986) tumbled 21.05% to HK$742.5. The trigger: 18 cornerstone investors will see a combined 14.39 million H-shares exit lockup on July 13.
This means → even though the company disclosed first-half net profit growth of roughly 1,099% (about RMB 6.9 billion), the looming supply of unlocked shares overwhelmed the earnings beat.
SMIC fell 4.67%, dragging the HSI down by 25.01 points on its own. Semis, PCBs, and optical-comms names all opened high and faded, becoming the day's biggest drag.
Which blue chips and momentum names stood out?
CK Hutchison led blue chips, up 7.53% at HK$70, contributing 20.07 points to the HSI. The catalyst: the company is in talks to sell its European perfume-and-cosmetics unit Marionnaud.
Leapmotor jumped 6.79% — first-half EV registrations in Italy soared 1,448.8% year-on-year, lifting its Italian BEV market share to 29.4%. Pegbio surged 28.93% after announcing an oral-delivery collaboration with Nasdaq-listed Rani Therapeutics targeting obesity.
Most mega-cap tech names closed higher: Xiaomi up over 3%, JD.com, Kuaishou, and Alibaba each up over 2%. CATL fell 7.92%, dragging the HSI down 15.99 points.
After the rotation, what comes next?
The afternoon flow was clear: money left chip hardware for commercial space and innovative pharma. Two IPOs debuted with divergent results — Nexchip held flat while Binhua dropped 18.68%, touching −24% intraday.
This means → the market is not rising uniformly; capital is choosing between sectors. Whether commercial space becomes a lasting theme depends on industrialization pace; whether pharma can hold its valuation hinges on mid-year earnings delivery.
In plain terms = today's rotation shows money is hunting for the next narrative, but how long the story lasts still comes down to whether fundamentals can keep up.
Content is for reference only, not financial advice.